Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21121019 | 0.89 | CASP2 (0.58) | CASP2TSHRRECQLSMN1; SMN2NAAA | |
| SCHEMBL17905796 | 0.89 | CASP2 (0.54) | CASP2TSHRRECQLNAAAALDH1A1 | |
| SCHEMBL17987709 | 0.88 | TSHR (0.59) | CASP2TSHRRECQLSMN1; SMN2NAAA | |
| SCHEMBL21538797 | 0.87 | CASP2 (0.60) | CASP2TSHRRECQLSMN1; SMN2NAAA | |
| SCHEMBL17723057 | 0.86 | CASP2 (0.55) | CASP2TSHRRECQLSMN1; SMN2NAAA | |
| SCHEMBL25792753 | 0.86 | CASP2 (0.48) | CASP2TSHRSMN1; SMN2NAAA | |
| SCHEMBL25961891 | 0.86 | CASP2 (0.48) | CASP2TSHRSMN1; SMN2NAAA | |
| SCHEMBL25887731 | 0.86 | MEN1 (0.57) | TSHRRECQLSMN1; SMN2ALDH1A1NPSR1 | |
| SCHEMBL13864788 | 0.85 | CASP2 (0.54) | CASP2TSHRNAAAFAAH | |
| SCHEMBL23288384 | 0.85 | CASP2 (0.67) | CASP2TSHRNAAAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022123462-A1 | RADIOLABELLED PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2022-06-16 | — | — | WO | disclosed |